US3342824A
(en)
*
|
1964-12-07 |
1967-09-19 |
Lilly Co Eli |
Normorphines
|
GB1123768A
(en)
*
|
1966-07-29 |
1968-08-14 |
Smith Kline French Lab |
New thebaine and oripavine derivatives and processes for preparing the same
|
US3466277A
(en)
*
|
1966-12-13 |
1969-09-09 |
Boehringer Sohn Ingelheim |
N-allylic cyclohexyl lower alkyl normorphines
|
US3905981A
(en)
*
|
1973-10-12 |
1975-09-16 |
Research Corp |
N-dealkylation of tertiary amines
|
NO802139L
(no)
*
|
1979-08-09 |
1981-02-10 |
Mallinckrodt Inc |
Utgangsforbindelser for fremstilling av morfinderivater, samt fremgangsmaate til fremstilling av utgangsforbindelsene
|
US4613668A
(en)
*
|
1983-12-22 |
1986-09-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Short total synthesis or morphinan compounds which uses cyclization of a cycloalkylcarbonyl compound selected from cyclopropylcarbonyl and cyclobutylcarbonyl
|
US4990617A
(en)
*
|
1985-12-02 |
1991-02-05 |
E. I. Du Pont De Nemours And Company |
N-oxide prodrug derivatives of 3-hydroxy morphinans and partial morphinans and derivatives
|
US4722928A
(en)
*
|
1985-12-02 |
1988-02-02 |
E. I. Du Pont De Nemours And Company |
N-oxide prodrug derivatives of 3-hydroxy morphinans and partial morphinans having improved oral bioavailability, pharmaceutical compositions, and processes
|
US5668285A
(en)
*
|
1986-10-31 |
1997-09-16 |
The United States Of America As Represented By The Department Of Health And Human Services |
Total synthesis of northebaine, normophine, noroxymorphone enantiomers and derivatives via N-Nor intermediates
|
WO1991005768A1
(fr)
*
|
1989-10-16 |
1991-05-02 |
The United States Of America, Represented By The Secretary, United States Department Of Commerce |
Synthese totale d'enantiomeres et de derives de northebaine, normorphine, neuroxymorphone par des intermediaires n-nor
|
US5028612A
(en)
*
|
1990-03-22 |
1991-07-02 |
Hillel Glover |
Method for treating emotional numbness
|
EP1782834A3
(fr)
*
|
2003-03-13 |
2007-08-01 |
Controlled Chemicals, Inc. |
Oxycodone conjugue avec un potentielle d'abus inférieur et une durée d'action étendue
|
WO2004082620A2
(fr)
*
|
2003-03-13 |
2004-09-30 |
Controlled Chemicals, Inc. |
Composes et methodes pour reduire l'abus potentiel d'un medicament et pour en prolonger la duree d'action
|
WO2006138020A2
(fr)
*
|
2005-06-16 |
2006-12-28 |
Mallinckrodt Inc. |
Trajet synthetique vers 14-hydroxyl opiates via 1-halo-thebaine ou analogues
|
WO2008064351A2
(fr)
*
|
2006-11-22 |
2008-05-29 |
Progenics Pharmaceuticals, Inc. |
(r)-n-stéréoisomères d'analogues 4,5-époxy-morphinanium saturé en position 7 et 8
|
CA2681740A1
(fr)
*
|
2007-03-23 |
2008-10-02 |
Mallinckrodt Inc. |
Preparation amelioree d'oxymorphone a partir d'oripavine
|
JP5393654B2
(ja)
|
2007-04-12 |
2014-01-22 |
イヴァックス インテルナツィオナール ゲゼルシャフト ミット ベシュレンクテル ハフツンク |
改善された心血管副作用プロフィールを呈する、ドーパミン受容体安定剤/調節剤のn−オキシド誘導体及び/又はジ−n−オキシド誘導体
|
JP5373764B2
(ja)
*
|
2007-04-16 |
2013-12-18 |
マリンクロッド エルエルシー |
触媒性水素転移反応を使用する新規なオピエート還元
|
CA2709882A1
(fr)
|
2007-12-17 |
2009-06-25 |
Peter X. Wang |
N-demethylation de n-methyl morphinanes
|
JP5688974B2
(ja)
*
|
2007-12-17 |
2015-03-25 |
マリンクロッド エルエルシー |
(+)−オピエートの生成のためのプロセスおよび化合物
|
WO2010039209A2
(fr)
*
|
2008-09-30 |
2010-04-08 |
Mallinckrodt Inc. |
Procédés de synthèse d'amines tertiaires
|
WO2011008636A1
(fr)
*
|
2009-07-15 |
2011-01-20 |
Mallinckrodt Inc. |
Dérivés de 3-oxy-hydromorphone
|